N-of-One
N-of-One is a leader in identifying patient-specific therapeutic options for precision medicine in oncology by leveraging its proprietary knowledgebase and its team of oncologists and Ph.D. scientists to integrate molecular data from multiple tests. Using N-of-One solutions can standardize and accelerate genomic clinical interpretation and molecular decision support while saving time and money. N-of-One's solutions have provided therapeutic options, including clinical trials, for tens of thousands of patient cases across hundreds of cancer types. N-of-One partners with leading hospital systems, cancer centers, and commercial labs around the world.
About N-of-One
Founded
2008Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$11MCategory
Industry
BiotechnologyLocation
City
ConcordState
MassachusettsCountry
United StatesN-of-One
Find your buyer within N-of-One